SXTC NASDAQ
China SXT Pharmaceuticals, Inc.
1W: -6.2%
1M: +8.6%
3M: +0.8%
YTD: -99.1%
1Y: +47.0%
3Y: -90.2%
5Y: -99.9%
$2.41
-0.55 (-18.58%)
Weekly Expected Move ±23.2%
$1
$2
$2
$3
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4M
-71.3% ▼
Capital Expenditures
$4
+99.8% ▲
5Y CAGR: -86.6%
Free Cash Flow
-$4M
-71.1% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$10M
+66.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$6M | -$6M | -$3M | -$3M | -$6M |
| Depreciation & Amort. | $320K | $250K | $203K | $82K | $143K |
| Stock-Based Comp. | $2M | $555K | $352K | $0 | $0 |
| Change in Working Capital | $2M | $1M | -$382K | -$972K | -$2M |
| Other Non-Cash Items | $1M | $409K | $997K | $2M | $4M |
| Operating Cash Flow | $268K | -$81K | -$2M | -$2M | -$4M |
| — Investing Activities — | |||||
| Capital Expenditures | -$62K | -$71K | -$7K | -$2K | -$1M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $16K | $58K | $33K | $66K | $0 |
| Investing Cash Flow | -$47K | -$12K | $26K | $64K | -$1M |
| — Financing Activities — | |||||
| Net Debt Issuance | $3M | $4M | $1M | -$65K | $144K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$4M | -$3M | -$4M | $6M | $0 |
| Financing Cash Flow | $2M | $3M | -$3M | $8M | $14M |
| Net Change in Cash | $2M | $2M | -$5M | $6M | $10M |
| Cash End of Period | $16M | $17M | $12M | $18M | $28M |
| Free Cash Flow | $206K | -$151K | -$2M | -$2M | -$4M |